The Cancer Biology (CB) research program aims to enhance interdisciplinary collaboration among basic and clinical scientists and facilitate translational research involving the etiology, treatment and prevention of cancer. CB program members study critical cellular processes that, when abnormal, contribute to the etiology of cancer. These processes include cell proliferation, cell differentiation and cell death along with a number of other basic underlying mechanisms of neoplasia. From a clinical standpoint, these studies directly affect our approach to:
- Kidney cancer
- GI cancers that include colon and liver cancer, polycystic kidney disease, chemical and alcohol induced liver injury and carcinogenesis, liver inflammation, stem cell homeostasis, and cancer treatment and prevention.